CIMCX
Price
$27.40
Change
+$0.08 (+0.29%)
Updated
Jun 2 closing price
Net Assets
146.54B
PDRDX
Price
$13.79
Change
+$0.15 (+1.10%)
Updated
Jun 2 closing price
Net Assets
2.68B
Interact to see
Advertisement

CIMCX vs PDRDX

Header iconCIMCX vs PDRDX Comparison
Open Charts CIMCX vs PDRDXBanner chart's image
CIMCX vs PDRDX Comparison Chart in %
View a ticker or compare two or three
VS
CIMCX vs. PDRDX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIMCX is a Buy and PDRDX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIMCX has more cash in the bank: 147B vs. PDRDX (2.68B). PDRDX pays higher dividends than CIMCX: PDRDX (3.82) vs CIMCX (2.73). CIMCX was incepted earlier than PDRDX: CIMCX (24 years) vs PDRDX (16 years). CIMCX (1.35) is less costly to investors than PDRDX (0.92). PDRDX is a more actively managed with annual turnover of: 85.90 vs. CIMCX (65.00). PDRDX has a lower initial minimum investment than CIMCX: PDRDX (0) vs CIMCX (250). PDRDX annual gain was more profitable for investors over the last year : 20.73 vs. CIMCX (8.06). PDRDX return over 5 years is better than : 23.03 vs. CIMCX (20.12).
CIMCXPDRDXCIMCX / PDRDX
Total Expense Ratio1.350.87155%
Annual Report Gross Expense Ratio1.350.92147%
Fund Existence24 years16 years-
Gain YTD5.65411.85148%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets147B2.68B5,493%
Annual Yield % from dividends2.733.8271%
Returns for 1 year8.0620.7339%
Returns for 3 years33.0737.1289%
Returns for 5 years20.1223.0387%
Returns for 10 years67.7069.1598%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JLCAX23.77N/A
N/A
JPMorgan US Large Cap Core Plus A
OINCX25.45N/A
N/A
JPMorgan Equity Income C
PHSKX37.47N/A
N/A
Virtus KAR Mid-Cap Growth A
MXNSX22.96N/A
N/A
Empower S&P SmallCap 600® Index L
RYCFX45.37N/A
N/A
Rydex Biotechnology C